NCT02513069

Brief Summary

The primary goal of the study is to evaluate the effectiveness of a combined tele-health and contingency management (CM) intervention that the investigators call mobile CM, or mCM, in promoting smoking abstinence in US Veterans. The mCM intervention will combine a mobile system to reward non-smoking, smoking cessation counseling, and smoking cessation medications. The primary aim is to evaluate how effective this intervention is in promoting smoking abstinence compared to telehealth interventions for smoking cessation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
291

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2015

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 14, 2019

Completed
Last Updated

February 21, 2020

Status Verified

February 1, 2020

Enrollment Period

4.1 years

First QC Date

July 28, 2015

Last Update Submit

February 19, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • smoking, self-report

    Participants' self-report of smoking in the past seven days will be measured at 6-month follow-up study visit.

    6 month follow-up (6 months post-quit attempt)

Secondary Outcomes (5)

  • saliva cotinine

    6 month follow-up (6 months post-quit attempt)

  • smoking, self-report

    Approx. ten weeks after enrollment (i.e., eight weeks after smoking quit attempt)

  • saliva cotinine

    Approx. ten weeks after enrollment (i.e., eight weeks after smoking quit attempt)

  • smoking, self-report

    3 month follow-up (3 months post-quit attempt)

  • saliva cotinine

    3 month follow-up (3 months post-quit attempt)

Study Arms (2)

Mobile Contingency Management (mCM)

EXPERIMENTAL

The mCM arm represents a proactive tele-health intervention that combines guideline based cognitive-behavioral smoking cessation telephone counseling, a tele-medicine clinic for access to nicotine replacement therapy (NRT), and intensive behavioral therapy administered via a smart phone (with carbon monoxide monitor) based application. NRT may include nicotine patches (21 mg, 14 mg, and or 7 mg) used daily for six weeks from the smoking quit date. Dosage will depend on participants' reported smoking patterns and carbon monoxide readings. NRT may also include a "rescue" method, i.e., either nicotine gum or nicotine lozenge. The participants' preferred NRT rescue method will be prescribed and used as needed to reduce smoking craving for six weeks from the smoking quit date.

Other: Nicotine gumBehavioral: mobile contingency managementBehavioral: Telephone counselingOther: Nicotine patchOther: Nicotine lozengeOther: Smart phoneOther: Carbon monoxide monitor

Tele-Health for Smoking Ccessation

ACTIVE COMPARATOR

TELE-HEALTH FOR SMOKING CESSATION is a proactive tele-health intervention that will provide controls for therapist, medication, time and attention effects. The tele-health intervention provides the same guideline based cognitive-behavioral smoking cessation telephone counseling, and tele-medicine clinic for access to NRT as in the mCM intervention. NRT may include nicotine patches (21 mg, 14 mg, and or 7 mg) used daily for six weeks from the smoking quit date. Dosage will depend on participants' reported smoking patterns and carbon monoxide readings. NRT may also include a "rescue" method, i.e., either nicotine gum or nicotine lozenge. The participants' preferred NRT rescue method will be prescribed and used as needed to reduce smoking craving for six weeks from the smoking quit date.

Other: Nicotine gumBehavioral: Telephone counselingOther: Nicotine patchOther: Nicotine lozenge

Interventions

Participants will be prescribed one form of nicotine replacement "rescue" treatment (i.e., gum, lozenge), and may choose nicotine gum as the preferred "rescue" treatment. Participants will be instructed to use the rescue method as needed during the post-quit phase of the study to reduce cigarette cravings.

Also known as: nicotine polacrilex
Mobile Contingency Management (mCM)Tele-Health for Smoking Ccessation

Participants will be asked to provide video recordings of themselves taking carbon monoxide readings in order to confirm smoking abstinence. Participants are asked to upload these videos to the study's secured server, and are provided reinforcement for videos that suggest smoking abstinence.

Also known as: mCM
Mobile Contingency Management (mCM)

Participants receive five sessions of cognitive-behavioral telephone counseling, and a participant manual. The telephone counseling protocol included in this application is based on standard cognitive-behavioral therapy techniques shown to be efficacious for smoking cessation and is informed by behavioral treatment principles .

Also known as: CBT for smoking cessation
Mobile Contingency Management (mCM)Tele-Health for Smoking Ccessation

Participants will be prescribed nicotine patches to be used during the post-quit phase of the study.

Also known as: Nicoderm
Mobile Contingency Management (mCM)Tele-Health for Smoking Ccessation

Participants will be prescribed one form of nicotine replacement "rescue" treatment (i.e., gum, lozenge), and may choose nicotine lozenge as the preferred "rescue" treatment. Participants will be instructed to use the rescue method as needed during the post-quit phase of the study to reduce cigarette cravings.

Mobile Contingency Management (mCM)Tele-Health for Smoking Ccessation

Participants in the experimental condition will be loaned a smart phone to use during the mobile contingency management intervention period. The phone will be used to record videos of carbon monoxide readings to determine smoking abstinence.

Mobile Contingency Management (mCM)

Participants in the experimental condition will be loaned a CO monitor to use during the mobile contingency management intervention period. The monitor will be used to determine carbon monoxide content in the breath as a measurement of smoking.

Also known as: CO monitor
Mobile Contingency Management (mCM)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Smoked at least 10 cigarettes on at least 15 of 30 days before screening
  • Served during OEF/OIF/OND era
  • Are willing to make a smoking cessation attempt
  • Enrolled in the Durham VA for ongoing care
  • English speaking

You may not qualify if:

  • Use and unwillingness to stop use of other forms of nicotine such as cigars, pipes, or chewing tobacco
  • Active diagnosis of a primary psychotic disorder per medical record
  • Are currently imprisoned or in psychiatric hospitalization
  • Severely impaired hearing or speech such that telephone counseling is not possible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27706, United States

Location

MeSH Terms

Conditions

Smoking

Interventions

Nicotine Chewing GumTobacco Use Cessation DevicesNicotine

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Chewing GumPlant GumsBiopolymersPolymersMacromolecular SubstancesPolysaccharidesCarbohydratesTherapeuticsCandyFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesSolanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-Ring

Study Officials

  • Patrick S Calhoun, Ph.D.

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2015

First Posted

July 31, 2015

Study Start

January 1, 2015

Primary Completion

February 14, 2019

Study Completion

February 14, 2019

Last Updated

February 21, 2020

Record last verified: 2020-02

Locations